totally disagree there, no FDA no takeover....simples. Also, shareholders would have to be onboard and if no approval in place then takeover price would be far too low for most to accept.
Ann: Results of Annual General Meeting, page-78
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #